| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/07/2005 | WO2005030954A1 Process for producing antigenic substance |
| 04/07/2005 | WO2005030136A2 Tumor vaccine |
| 04/07/2005 | WO2004081033A3 Synthesis of proteins by cell-free protein expression |
| 04/07/2005 | WO2004074446A3 Parkin interacting polypeptides and methods of use |
| 04/07/2005 | WO2004048922A3 Bead-based detection of ligand-gpcr-g protein complexes |
| 04/07/2005 | WO2003093452A3 Variants of nedd4l associated with hypertension and viral budding |
| 04/07/2005 | US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075488 Interleukin-1 beta antibodies |
| 04/07/2005 | US20050075289 coagulation proteins or polypeptides having specific predetermined patterns of asparagine-linked (N-linked) oligosaccharides, used for treating a Factor VII-responsive syndromes such as haemophilia, Factor XI deficiency, Factor VII deficiency, thrombocytopenia, von Willebrand's disease; blood disorders |
| 04/07/2005 | US20050074855 High affinity fusion proteins and therapeutic and diagnostic methods for use |
| 04/07/2005 | US20050074853 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 04/07/2005 | US20050074844 Using alteration in bacterial gene expression profiles as tool in determining efficacy of microbiocides |
| 04/07/2005 | US20050074843 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074840 Folded recombinant tumor necrosis polypeptide comprising substituted proline for use as tool in treatment of inflammatory disorders |
| 04/07/2005 | US20050074839 Novel survivin interacting protein tpr1 |
| 04/07/2005 | US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/07/2005 | US20050074835 Transgenic yeast comprising glutathione synthetase for use as tool in improving food flavor and taste |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074762 Nucleotide sequences coding hormone protein for use in prevention and treatment of arteriosclerosis, diabetes, obesity and liver disorders |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074755 Nucleotide sequences coding mutator locus gene for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/07/2005 | US20050074460 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | US20050073473 Segmented character display |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540472A1 Method of in situ detection of proteins using aptamers |
| 04/07/2005 | CA2540446A1 Polypeptide cleavage method using ompt protease variant |
| 04/07/2005 | CA2540283A1 Tumor vaccine |
| 04/07/2005 | CA2540049A1 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 04/07/2005 | CA2538852A1 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 04/07/2005 | CA2537876A1 Antibodies to m-csf |
| 04/07/2005 | CA2537340A1 Leader sequences for use in production of proteins |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |
| 04/06/2005 | EP1520040A2 Microarrays displaying encoded molecules |
| 04/06/2005 | EP1520031A2 Proteolytic fermenter |
| 04/06/2005 | EP1520024A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 04/06/2005 | EP1520019A2 Adapter-directed display system |
| 04/06/2005 | EP1520008A1 Animal protein free media for cultivation of cells |
| 04/06/2005 | EP1519979A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519946A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/06/2005 | EP1519747A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1360282B1 Method for inactivation of TSE |
| 04/06/2005 | EP1326983B1 Gene cluster for ramoplanin biosynthesis |
| 04/06/2005 | EP1101118B1 Immunological determination of the hydrophobic pulmonary surfactant protein SP-C |
| 04/06/2005 | EP1003873B1 Increasing production of proteins in gram-positive microorganisms |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | EP0793727B1 Production of variant nisin |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604792A Agents for enhancing the immune response |
| 04/06/2005 | CN1603420A Enzymolysis method for preparing protein oligopeptide powder using Pacific Ocean alaska pollack |
| 04/06/2005 | CN1603415A Fusion expression method of mycobacterium tuberculosis ESAT-6 protein in pichia |
| 04/06/2005 | CN1603345A Trivalent bispecific antibody and its preparation process and use |
| 04/06/2005 | CN1195869C Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 04/06/2005 | CN1195868C In vitro human B lymphocyte immunizing process to produce human monoclonal antibody |
| 04/06/2005 | CN1195859C Modified human granulocyte-colony stimulating factor and process for producing same |
| 04/06/2005 | CN1195856C 启动子 Promoter |
| 04/06/2005 | CN1195853C Neurotrophic factor NNT-1 |
| 04/06/2005 | CN1195849C APPIL-a novel protein with growth effects |
| 04/06/2005 | CN1195844C Avian primordial germ cell (PGC) cell line and method for long term culturing thereof |
| 04/06/2005 | CN1195779C Double-specificity antibody resisting human ovary cancer and human CD3 |
| 04/06/2005 | CN1195777C Novel insulin derivatives having rapid onset of action |
| 04/06/2005 | CN1195774C HEV antigenic peptide and its method |
| 04/05/2005 | US6875845 Polypeptide for use in the treatment of cancer |
| 04/05/2005 | US6875592 Methods for the detection, analysis and isolation of nascent proteins |
| 04/05/2005 | US6875590 Nucleotide sequences coding polypeptide for use as tools in genetic engineering |
| 04/05/2005 | US6875574 Assays for sensory modulators using a sensory cell specific G-protein alpha subunit |
| 04/05/2005 | CA2203540C Major outer membrane protein cd of moraxella |
| 04/05/2005 | CA2116449C Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005029452A2 Segmented character display |
| 03/31/2005 | WO2005028660A1 PROCESS FOR PRODUCING α-GLYCOSYLATED DIPEPTIDE AND METHOD OF ASSAYING α-GLYCOSYLATED DIPEPTIDE |
| 03/31/2005 | WO2005028644A1 Construction of group of diversified protein molecules by frame shuffling |
| 03/31/2005 | WO2005028630A2 Engineered zinc finger proteins for regulation of gene expression |
| 03/31/2005 | WO2005028515A1 Recombinant antibody against human insulin-like growth factor |
| 03/31/2005 | WO2005027970A1 Drugs for treating cancer |
| 03/31/2005 | WO2005027962A1 4’-thionucleosides and oligomeric compounds |
| 03/31/2005 | WO2005012495A3 Methods for expression and purification of immunotoxins |
| 03/31/2005 | WO2005007800A3 Monoclonal antibody against platelet membrane glycoprotein vi |
| 03/31/2005 | WO2004085664B1 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use |
| 03/31/2005 | WO2004080579A3 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells |
| 03/31/2005 | WO2004044167A3 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 03/31/2005 | WO2004039234A3 Humanized antibodies against the venezuelan equine encephalitis virus |
| 03/31/2005 | WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2005 | US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders |
| 03/31/2005 | US20050070696 Propagating and isolating cell growth factors from prokaryotic systems using ion exchange and reverse phase chromatography; bioreactor and heterologous gene expression |
| 03/31/2005 | US20050070694 Antagonistic anti-htnfsf13b human antibodies |
| 03/31/2005 | US20050070692 Anti-interleukin-1 beta analogs |
| 03/31/2005 | US20050070691 Polypeptides of moraxella (branhamella) catarrhalis |
| 03/31/2005 | US20050070690 Producing tyrosine kinase receptor-related polypeptide for use in tools in identifying modulator for treatment of cell proliferative disorders; biosensors |